Kymera Therapeutics Stock Price on July 10, 2024

KYMR Stock  USD 40.82  0.03  0.07%   
If you're considering investing in Kymera Stock, it is important to understand the factors that can impact its price. As of today, the current price of Kymera Therapeutics stands at 40.82, as last reported on the 24th of December, with the highest price reaching 41.71 and the lowest price hitting 40.14 during the day. Kymera Therapeutics has Sharpe Ratio of -0.0959, which conveys that the firm had a -0.0959% return per unit of risk over the last 3 months. Kymera Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Kymera Therapeutics' Mean Deviation of 2.55, risk adjusted performance of (0.07), and Standard Deviation of 3.31 to check out the risk estimate we provide.
  
Kymera Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0959

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsKYMR

Estimated Market Risk

 3.31
  actual daily
29
71% of assets are more volatile

Expected Return

 -0.32
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.1
  actual daily
0
Most of other assets perform better
Based on monthly moving average Kymera Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kymera Therapeutics by adding Kymera Therapeutics to a well-diversified portfolio.

Related Headline

C4 Therapeutics Headline on 10th of July 2024

Filed transaction by C4 Therapeutics Officer: Chief Medical Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Kymera Therapeutics Valuation on July 10, 2024

It is possible to determine the worth of Kymera Therapeutics on a given historical date. On July 10, 2024 Kymera was worth 39.44 at the beginning of the trading date compared to the closed value of 36.25. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Kymera Therapeutics stock. Still, in general, we apply an absolute valuation method to find Kymera Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Kymera Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Kymera Therapeutics' related companies.
 Open High Low Close Volume
  35.67    39.95    34.60    39.44    2,908,337  
07/10/2024
  39.44    39.45    35.23    36.25    832,840  
  37.45    39.57    37.16    39.00    1,086,725  
Backtest Kymera Therapeutics  |  Kymera Therapeutics History  |  Kymera Therapeutics Valuation   PreviousNext  
Open Value
39.44
36.25
Closing Value
49.37
Upside

Kymera Therapeutics Trading Date Momentum on July 10, 2024

On July 11 2024 Kymera Therapeutics was traded for  39.00  at the closing time. The top price for the day was 39.57  and the lowest listed price was  37.16 . The trading volume for the day was 1.1 M. The trading history from July 11, 2024 was a factor to the next trading day price gain. The trading delta at closing time against the next closing price was 7.59% . The trading delta at closing time against the current closing price is 19.94% .

Kymera Therapeutics Fundamentals Correlations and Trends

By evaluating Kymera Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Kymera Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Kymera financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Kymera Therapeutics Stock history

Kymera Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Kymera is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Kymera Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Kymera Therapeutics stock prices may prove useful in developing a viable investing in Kymera Therapeutics
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the bodys own natural protein degradation system. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts. Kymera Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 160 people.

Kymera Therapeutics Stock Technical Analysis

Kymera Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Kymera Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Kymera Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Kymera Therapeutics Period Price Range

Low
December 24, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Kymera Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Kymera Therapeutics December 24, 2024 Market Strength

Market strength indicators help investors to evaluate how Kymera Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kymera Therapeutics shares will generate the highest return on investment. By undertsting and applying Kymera Therapeutics stock market strength indicators, traders can identify Kymera Therapeutics entry and exit signals to maximize returns

Kymera Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Kymera Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Kymera Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Kymera to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Kymera Stock Analysis

When running Kymera Therapeutics' price analysis, check to measure Kymera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kymera Therapeutics is operating at the current time. Most of Kymera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Kymera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kymera Therapeutics' price. Additionally, you may evaluate how the addition of Kymera Therapeutics to your portfolios can decrease your overall portfolio volatility.